FIBROGEN, INC.

FGEN
Delayed Quote. Delayed  - 10/19 04:00:00 pm
45.76USD -0.78%
Prev.46.1200
Open46.4000
High46.7800
Low45.4600
Volume524 987
Latest news
4d ago
5d ago
5d ago
09/08
Chart FIBROGEN, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance49,049,048,8
Spread/Res.-6,6%-6,6%-6,3%
Spread/Supp.1,6%12%31%
Support45,041,035,0
Financials
Sales 2020 265 M - -
Net income 2020 -223 M - -
Net Debt 2020 - - -
P/E ratio 2020 -18,5x
Yield 2020 -
Capitalization 4 167 M 4 167 M -
Capi. / Sales 2020 15,7x
Capi. / Sales 2021 8,14x
Nbr of Employees 531
Free-Float 91,8%
Company
FibroGen, Inc. is a science-based biopharmaceutical company discovering and developing a pipeline of first- in-class therapeutics. The Company is focused on fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia,...

>> Read more
Sector :
Biotechnology & Medical Research - NEC
Calendar :
2020-11-04 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 62,00 $
Last Close Price 46,12 $
Spread / Highest target 82,1%
Spread / Average Target 34,4%
Spread / Lowest Target -4,60%